Ülke: Singapur
Dil: İngilizce
Kaynak: HSA (Health Sciences Authority)
Diphtheria toxoid
GLAXOSMITHKLINE PTE LTD
J07CA02
2.5 Lf/0.5 ml
INJECTION, SUSPENSION
INTRAMUSCULAR
Prescription Only
GlaxoSmithKline Biologicals s.a.
2006-02-14
three purified pertussis antigens [pertussis toxoid (PT), filamentous hemagglutinin (FHA) and pertactin (PRN/69 kiloDalton outer membrane protein)] adsorbed onto aluminium salts. It contains three types of inactivated polio viruses (type 1: Mahoney strain; type 2: MEF-1 strain; type 3: Saukett strain). The tetanus and diphtheria toxoids are obtained by formaldehyde treatment of purified _Corynebacterium diphtheriae_ and _Clostridium tetani toxins_. The acellular pertussis vaccine components are obtained by extraction and purification from phase I _Bordetella pertussis_ cultures, followed by irreversible detoxification of the pertussis toxin by glutaraldehyde and formaldehyde treatment of pertussis toxin, and formaldehyde treatment of FHA and PRN. The diphtheria toxoid, tetanus toxoid and acellular pertussis components are adsorbed onto aluminium salts. The three polioviruses are cultivated on a continuous VERO cell line, purified and inactivated with formaldehyde. BOOSTRIX ™ POLIO meets the World Health Organisation requirements for the manufacture of biological substances, of diphtheria, tetanus, pertussis combined vaccines, and of inactivated poliomyelitis vaccines. A 0.5 ml dose of vaccine contains not less than 2 IU (2.5 Lf) of adsorbed diphtheria toxoid, not less than 20 IU (5 Lf) of adsorbed tetanus toxoid, 8 μg of PT, 8 μ of FHA, 2.5 μg of pertactin, 40 D antigen units of type 1 (Mahoney), 8 D antigen units of type 2 (MEF-1) and 32 D antigen units of type 3 (Saukett) of the polio virus. 3. PHARMACEUTICAL FORM Suspension for injection. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS BOOSTRIX ™ POLIO is indicated for booster vaccination against diphtheria, tetanus, pertussis and poliomyelitis of individuals from the age of four years onwards. BOOSTRIX ™ POLIO is not intended for primary immunisation. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY A single 0.5 ml dose of the vaccine is recommended. BOOSTRIX ™ POLIO may be administered from the age of four years onwards. Belgenin tamamını okuyun